Levothyroxine

Revision as of 22:02, 26 December 2016 by ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: Endocrine *Dosage Forms: *Routes of Administration: PO, IV *Common Trade Names: Synthroid ==Adult Dosing== *Myxedema coma: 300-500 mcg IV x1, th...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Administration

  • Type: Endocrine
  • Dosage Forms:
  • Routes of Administration: PO, IV
  • Common Trade Names: Synthroid

Adult Dosing

Pediatric Dosing

Special Populations

Contraindications

  • Allergy to class/drug, hypersensitivity to glycerol
  • Uncorrected adrenal insufficiency (may precipitate acute adrenal crisis)
  • Acute MI
  • Subclinical or overt thyrotoxicosis, nontoxic diffuse goiter, nodular thyroid disease

Adverse Reactions

Serious

  • MI, heart failure, tachycardia, cardiac arrest
  • Pseudotumor, seizure
  • Dyspnea
  • Hyperthyroid
  • Decreased bone mineral density, hip fracture

Common

  • Palpitations
  • Diarrhea
  • Anxiety, insomnia, fatigue, sweating, weight loss
  • Alopecia

Pharmacology

  • Half-life: 6-7 days
  • Metabolism: Hepatic
  • Excretion: Renal, fecal

Mechanism of Action

  • Synthetic thyroid hormone (T3)

Comments

See Also

References